Alnuctamab (Anti-BCMA & CD3)
£595.50
Alnuctamab (Anti-BCMA & CD3) (A4030-1mg)
Product
| Cat # A4030-1mg | Size 1mg |
Price
£595.50
|
Qty
|
Description
Alnuctamab is a bispecific T-cell engager (BiTE) antibody directed against the tumor-associated antigen (TAA) human B-cell maturation antigen (BCMA; TNFRSF17) and the T-cell surface antigen CD3, with potential immunostimulating and antineoplastic activities. It demonstrates encouraging antitumor activity in patients with relapsed or refractory multiple myeloma. MW: 192.35 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Product Size | 1mg |
| Manufacturer Cat# | A4030 |
| Target | CD markers |